What is the price of Avatrombopag/Sucoxin in 2024?

Avatrombopag/Avatrombopag is used to treat thrombocytopenia (low number of platelets [the type of blood cells needed for clotting]) in people with chronic (ongoing) liver disease who are scheduled to have medical or dental procedures to help prevent bleeding complications. It is also used to treat thrombocytopenia in people with chronic immune thrombocytopenia (ITP; an ongoing disorder that may cause abnormal bruising or bleeding due to an abnormally low number of platelets in the blood) who are not helped by other treatments. Avatrombopag belongs to the thrombopoietin (TPO) receptor agonist class of drugs. It works by causing the body to produce more platelets.

Avatrombopag is available as an oral tablet. Treatment of thrombocytopenia in patients with chronic liver disease scheduled for surgery usually begins 10 to 13 days before surgery and is taken once daily with food for 5 days. For the treatment of thrombocytopenia in patients with ITP, it is usually taken once daily with food as directed. Take avatrombopag at about the same time each day, and do not take more, less, or more than your doctor prescribes.

The original drug of avatrombopag has been launched in the domestic market and has been included in Class B medical insurance, but reimbursement is limited to eligible patients. Its common specifications are 20mg15 tablets and 20mg10 tablets per box, with a price of about 7,000 yuan. Overseas, the price of this original drug is even higher. However, generic drugs of avatrombopag have been launched overseas, and their ingredients are basically the same as the original drug. For example, Laos Pharmaceutical’s 20mg*30 tablets are priced at more than 500 yuan per box. However, it is necessary to pay attention to possible price fluctuations caused by exchange rate changes.